Antimalarial drugs show potential for treating chronic lung infections caused by Mycobacterium abscessus, which would improve the quality of life for patients with limited treatment options.
Mary Jackson joined the Conviction et Engagement Avec la Fondation Raoul-Follereau podcast to discuss state of funding for leprosy research.
Using the only approved TB vaccine, Mary Jackson and her research team are developing a novel COVID-19 vaccine candidate.
On International Women’s Day, CSU celebrate the contributions and impact of women everywhere.
Animal research, including adaption of an existing TB vaccine, greatly contribute to the understanding of and response to SARS-COV-2.
CSU infectious disease scientists are continuing efforts on four unique projects to develop a possible COVID-19 vaccine.
A research team led by Mary Jackson are investigating if the BCG vaccine platform can effectively fight COVID-19.
A CSU-led international team has indentified that contact with armadillos resulted in high Mycobacterium leprae infection rates.
CSU research on how infectious diseases interact with amoebae may shed light on how the plague outbreaks can re-emerge.